Hiding in Plain Sight: Soluble Immunomodulatory Receptors

Lekh N Dahal (Corresponding Author), Herbert Schwarz, Frank J Ward

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Alternatively spliced natural soluble isoforms of immunomodulatory receptors [cytotoxic T lymphocyte antigen-4 (CTLA-4), 4-1BB, and programmed death-1 (PD-1)/PD-L1] have been overlooked in favor of their cell-surface-bound counterparts that have generated blockbuster antibodies for the treatment of cancer. We propose that the soluble variants of these receptors contribute to immune regulation and offer potential as targets for immunotherapy.

Original languageEnglish
Pages (from-to)771-774
Number of pages4
JournalTrends in Immunology
Volume39
Issue number10
Early online date5 Sep 2018
DOIs
Publication statusPublished - Oct 2018

Fingerprint

CTLA-4 Antigen
Immunotherapy
Protein Isoforms
Antibodies
Neoplasms
Therapeutics

Cite this

Hiding in Plain Sight : Soluble Immunomodulatory Receptors. / Dahal, Lekh N (Corresponding Author); Schwarz, Herbert; Ward, Frank J.

In: Trends in Immunology, Vol. 39, No. 10, 10.2018, p. 771-774.

Research output: Contribution to journalArticle

Dahal, Lekh N ; Schwarz, Herbert ; Ward, Frank J. / Hiding in Plain Sight : Soluble Immunomodulatory Receptors. In: Trends in Immunology. 2018 ; Vol. 39, No. 10. pp. 771-774.
@article{63d080fb1cc241ec8af7815ea892d109,
title = "Hiding in Plain Sight: Soluble Immunomodulatory Receptors",
abstract = "Alternatively spliced natural soluble isoforms of immunomodulatory receptors [cytotoxic T lymphocyte antigen-4 (CTLA-4), 4-1BB, and programmed death-1 (PD-1)/PD-L1] have been overlooked in favor of their cell-surface-bound counterparts that have generated blockbuster antibodies for the treatment of cancer. We propose that the soluble variants of these receptors contribute to immune regulation and offer potential as targets for immunotherapy.",
author = "Dahal, {Lekh N} and Herbert Schwarz and Ward, {Frank J}",
note = "We thank Professor Mark S. Cragg, Centre for Cancer Immunology, Faculty of Medicine, University of Southampton, Southampton, UK for critical reading of the manuscript.",
year = "2018",
month = "10",
doi = "10.1016/j.it.2018.08.004",
language = "English",
volume = "39",
pages = "771--774",
journal = "Trends in Immunology",
issn = "1471-4906",
publisher = "Elsevier Limited",
number = "10",

}

TY - JOUR

T1 - Hiding in Plain Sight

T2 - Soluble Immunomodulatory Receptors

AU - Dahal, Lekh N

AU - Schwarz, Herbert

AU - Ward, Frank J

N1 - We thank Professor Mark S. Cragg, Centre for Cancer Immunology, Faculty of Medicine, University of Southampton, Southampton, UK for critical reading of the manuscript.

PY - 2018/10

Y1 - 2018/10

N2 - Alternatively spliced natural soluble isoforms of immunomodulatory receptors [cytotoxic T lymphocyte antigen-4 (CTLA-4), 4-1BB, and programmed death-1 (PD-1)/PD-L1] have been overlooked in favor of their cell-surface-bound counterparts that have generated blockbuster antibodies for the treatment of cancer. We propose that the soluble variants of these receptors contribute to immune regulation and offer potential as targets for immunotherapy.

AB - Alternatively spliced natural soluble isoforms of immunomodulatory receptors [cytotoxic T lymphocyte antigen-4 (CTLA-4), 4-1BB, and programmed death-1 (PD-1)/PD-L1] have been overlooked in favor of their cell-surface-bound counterparts that have generated blockbuster antibodies for the treatment of cancer. We propose that the soluble variants of these receptors contribute to immune regulation and offer potential as targets for immunotherapy.

U2 - 10.1016/j.it.2018.08.004

DO - 10.1016/j.it.2018.08.004

M3 - Article

C2 - 30195467

VL - 39

SP - 771

EP - 774

JO - Trends in Immunology

JF - Trends in Immunology

SN - 1471-4906

IS - 10

ER -